title: Eliminating transfusion in primary joint arthroplasty-an achievable goal.
authors.forename: Viktor
authors.initials: V
authors.lastname: Krebs
authors.forename: W J
authors.initials: WJ
authors.lastname: Hozack
authors.forename: John J
authors.initials: JJ
authors.lastname: Callaghan
authors.forename: J
authors.initials: J
authors.lastname: Bohannon Mason
authors.forename: Michael
authors.initials: M
authors.lastname: Mont
authors.forename: Javad
authors.initials: J
authors.lastname: Parvizi
mesh_terms: D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001178:Arthroplasty / Q000009:adverse effects*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001803:Blood Transfusion; D006040:Goals; D006801:Humans; D014148:Tranexamic Acid / Q000627:therapeutic use*
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid